Skip to content
跳至主要內容
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
個股明細
Loading institutional stock data...
← BACK TO COCKPIT
ALL TICKERS →
OPTIONS CHAIN →
TNYA
Tenaya Therapeutics, Inc.
NASDAQCM
Biotechnology
United States
$0.6832
▼
-0.01 (-1.74%)
CLOSED
—
OPEN
$0.6900
HIGH
$0.7096
LOW
$0.6811
PREV CLOSE
$0.6953
VOLUME
1.19M
0.54x avg
BID / ASK
0.49 / 0.89
spr 0.398
MARKET CAP
$153.2M
DAY RANGE
$0.68
$0.71
P/E (TTM)
—
Fwd -1.7
EPS (TTM)
-0.51
DIV YIELD
—
52W HIGH
$2.35
-70.9%
52W LOW
$0.5320
+28.4%
BETA
2.78
vs S&P 500
DES
FA
GP
OPT
HLDR
EARN
CMP
COMPARE
ASK DESK
AFTER-HOURS
$0.685
+0.00
(+0.26%)
LAST SURPRISE
—
—
NEXT EARNINGS
—
—
CATALYST
No fresh catalyst
—
ANALYST
—
—
SHORT INT
—
—
OPTIONS IV
—
—
TNYA
$0.6832
▼
-1.74%
Chart
Valuation
Financials
Peers
News
TNYA · K 線技術分析（即時、可互動）
basic
pro
快速分析（約半分鐘，最長 5 分鐘）
K 線圖載入中…
按上方「快速分析」，研究台會以這張 K 線為起點跑一輪快速回答：三個分析師視角（總經、基本面、技術面）加交易計畫與風險統計，通常約半分鐘，上游壅塞時最長 5 分鐘。想要五隊深度研究與機構級報告，請在研究台把模式切到「深度」。
1-YEAR PRICE
一年走勢
RISK-OFF
252 BARS · -49.4% YOY
1-year price chart. Started at 1.35, currently 0.68, down 49.4 percent. Range 0.55 to 2.10 over 252 data points.
2025-09-05
$1.35 → $0.68 (-49.4%)
2026-09-04
§ Valuation
Loading § Valuation
§ Multi-Year Financials
Loading § Multi-Year Financials
§ Peers
Loading § Peers
§ Recent News
Loading § Recent News
編輯內容 · 非投資建議。
資料來源：Finnhub（報價 / 公司資料 / 新聞 / 同業）＋ Yahoo（統計）＋ SEC EDGAR XBRL（財務 + DCF）。伺服器端數值經 ISR 快取，最長 60 分鐘；報價則在你的瀏覽器裡即時更新。
VALUATION
確定性估值（SEC EDGAR + Finnhub）
—
NO DCF
DCF Fair Value
—
DCF vs Spot
—
Comps Fair Value
—
WACC Used
+12.0%
Terminal g
+2.5%
⚠ DCF skipped: missing FCF or shares data from SEC EDGAR. Often the case for non-US issuers. · Cohort refused: no sector classification for TNYA, so its peer set cannot be validated and is not published.
FINANCIALS
多年財務（SEC XBRL）
—
4 FY · NO YOY
FY
Revenue
Net Income
OCF
FCF
Assets
2025-12
—
-$90.6M
-$68.3M
-$68.9M
$146.9M
2024-12
—
-$111.1M
-$90.5M
-$91.5M
$119.9M
2023-12
—
-$124.1M
-$102.1M
-$103.3M
$170.5M
2022-12
—
-$123.7M
-$104.4M
-$125.1M
$278.9M
PEERS
同業與產業對照
CALM
10 PEERS · FINNHUB
CRBU
HUMA
SPRB
INDP
OTLK
INO
BMEA
OKUR
UNCY
EQ
NEWS
近期新聞（過去 14 天）
CALM
9 HEADLINES · LAST 14 DAYS
Tenaya Therapeutics to Participate in Upcoming September Investor Conferences
GlobeNewswire · 2026-09-03
Tenaya Therapeutics Eyes Q4 Updates for Cardiac Gene Therapies, TN-301
MarketBeat · 2026-08-18
Tenaya Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire · 2026-08-05
Tenaya Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference
GlobeNewswire · 2026-08-04
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire · 2026-07-15
Tenaya Therapeutics Names Eric Hyllengren CFO
MT Newswires · 2026-06-29
Tenaya Therapeutics Appoints Eric Hyllengren as Chief Financial Officer
GlobeNewswire · 2026-06-29
Exploring 3 High Growth Tech Stocks in US Market
Simply Wall St. · 2026-06-15